Glenmede Trust CO Na Aclaris Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $111 - $200	-74 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $1,407 - $4,401	-1,782 Reduced 96.01%	74 $0
Q2 2019 Aug 13, 2019	SELL	$2.13 - $7.06 $728 - $2,414	-342 Reduced 15.56%	1,856 $4,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $11,491 - $28,089	1,824 Added 487.7%	2,198 $16,000
Q2 2018 Aug 15, 2018	BUY	$16.46 - $20.33 $6,156 - $7,603	374 New	374 $7,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.